CDKN2B and chronic myelogenous leukemia, BCR-ABL1 positive: Activation of these enzymes in LSCs results in the hypermethylation of cyclin-dependent kinase inhibitor p15INK4B in patients with acute myeloid leukemia (AML) and acute phase of chronic myeloid leukemia (CML)   18 .